Keywords
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les pandémies grippales - Analysis (France)

Index « Keywords » - entrée « Immunogenicity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunodominant Epitopes (immunology) < Immunogenicity < Immunologic Factors (therapeutic use)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000459 (2014) Corinne Pion [France] ; Virginie Courtois [France] ; Stéphanie Husson [France] ; Marie-Clotilde Bernard [France] ; Marie-Claire Nicolai [France] ; Philippe Talaga [France] ; Emanuelle Trannoy [France] ; Catherine Moste [France] ; Régis Sodoyer [France] ; Isabelle Legastelois [France]Characterization and immunogenicity in mice of recombinant influenza haemagglutinins produced in Leishmania tarentolae
000472 (2013-09-16) Odile Launay [France] ; Xavier Duval [France] ; Serge Fitoussi [France] ; Wolfgang Jilg [Allemagne] ; Angkool Kerdpanich [Thaïlande] ; May Montellano [Philippines] ; Tino Schwarz [Allemagne] ; Veerachai Watanveerade [Thaïlande] ; Jürgen Wenzel [Allemagne] ; Gerard Zalcman [France] ; Vinod Bambure [Inde] ; Ping Li [États-Unis] ; Adrian Caplanusi [Belgique] ; Anuradha Madan [États-Unis] ; Paul Gillard [Belgique] ; David Vaughn [États-Unis]Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.
000538 (2013) Carlos A. Diazgranados [États-Unis] ; Andrew J. Dunning [États-Unis] ; Emilia Jordanov [États-Unis] ; Victoria Landolfi [États-Unis] ; Martine Denis [France] ; H. Keipp Talbot [États-Unis]High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season
000631 (2012) B. Rousseau [France] ; P. Loulergue [France] ; O. Mir [France] ; A. Krivine [France] ; S. Kotti [France] ; E. Viel [France] ; T. Simon [France] ; A. De Gramont [France] ; F. Goldwasser [France] ; O. Launay [France] ; C. Tournigand [France]Immunogenicity and safety of the influenza A HINIv 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
000632 (2012) A. Kostianovsky [France] ; P. Charles [France] ; J.-F. Alves [France] ; M. Goulet [France] ; C. Pagnoux [France] ; V. Le Guern [France] ; L. Mouthon [France] ; A. Krivine [France] ; P. Villiger [France, Suisse] ; O. Launay [France] ; L. Guillevin [France]Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients
000722 (2011) Odile Launay [France] ; Corinne Desaint [France] ; Christine Durier [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Christine Jacomet [France] ; Gilles Pialoux [France] ; Jade Ghosn [France] ; François Raffi [France] ; David Rey [France] ; Faiza Ajana [France] ; Nathalie Colin De Verdiere [France] ; Jacques Reynes [France] ; Valérie Foubert [France] ; François Roman [Belgique] ; Jeanne-Marie Devaster [Belgique] ; Jean-Frangois Delfraissy [France] ; Jean-Pierre Aboulker [France]Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial
000843 (2010) Catherine Caillet [France] ; Fabienne Piras [France] ; Marie-Clotilde Bernard [France] ; Aymeric De Montfort [France] ; Florence Boudet [France] ; Frederick R. Vogel [France] ; Agnès Hoffenbach [France] ; Catherine Moste [France] ; Inca Kusters [France]AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice
000975 (2008) Gregory A. Poland [États-Unis] ; Suryaprakash Sambhara [États-Unis] ; Karin Levie [Belgique] ; Isabel Leroux-Roels [Belgique] ; Karel Hoppenbrouwers [Belgique] ; Anne-Diane Kervyn [Belgique] ; Corinne Vandermeulen [Belgique] ; Sheron Forgus [Belgique] ; Geert Leroux-Roels [Belgique] ; Sylvie Pichon [France] ; Inca Kusters [France]An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults. Commentary

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i -k "Immunogenicity" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i  \
                -Sk "Immunogenicity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Immunogenicity
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021